Sugi Predict

Sugi Predict / Compounds / SCHEMBL29437937

SCHEMBL29437937

SCHEMBL29437937

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)C(C)C

nearest known ligand 0.63

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 2/20 0.63
▸ CTSB P07858 2/20 0.63
▸ DPP3 Q9NY33 5/20 0.55
▸ CXCR4 P61073 1/20 0.53
▸ NTSR2 O95665 1/20 0.53
▸ NTSR1 P30989 1/20 0.53
▸ SORT1 Q99523 1/20 0.53
▸ KISS1R Q969F8 4/20 0.50
▸ CXCL8 P10145 5/20 0.50
▸ PTGS1 P23219 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30477480 0.99 CAPN1 (0.65) CAPN1CTSBDPP3CXCR4NTSR2
SCHEMBL30224116 0.96 CAPN1 (0.64) CAPN1CTSBDPP3CXCR4NTSR2
SCHEMBL29437939 0.94 CAPN1 (0.60) CAPN1CTSBDPP3CXCR4NTSR2
SCHEMBL29437938 0.94 CAPN1 (0.61) CAPN1CTSBDPP3CXCR4NTSR2
SCHEMBL29437935 0.92 DPP3 (0.58) CAPN1CTSBDPP3CXCR4NTSR2
SCHEMBL29555002 0.86 CAPN1 (0.54) CAPN1CTSBDPP3CXCR4
SCHEMBL31357907 0.85 CAPN1 (0.57) CAPN1CTSBDPP3CXCR4NTSR2
SCHEMBL29416081 0.84 DPP3 (0.58) CAPN1CTSBDPP3CXCR4KISS1R
SCHEMBL30442994 0.84 DPP3 (0.56) CAPN1CTSBDPP3CXCR4NTSR2
SCHEMBL32677411 0.83 DPP3 (0.58) CAPN1CTSBDPP3CXCR4CXCL8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321241-A1 CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) 2023-10-12 — — US claimed
CN-116261450-A Cancer peptide vaccine and preparation method thereof 亮径生物疗法有限公司 2023-06-13 — — CN claimed
WO-2023013755-A1 CANCER PEPTIDE VACCINE COCKTAIL FORMULATION AMD METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2023-02-09 — — WO claimed
WO-2022025093-A1 CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2022-02-03 — — WO claimed
US-20230321241-A1 CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) 2023-10-12 — — US disclosed
US-20230321241-A1 CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) 2023-10-12 — — US disclosed
CN-116261450-A Cancer peptide vaccine and preparation method thereof 亮径生物疗法有限公司 2023-06-13 — — CN disclosed
CN-116261450-A Cancer peptide vaccine and preparation method thereof 亮径生物疗法有限公司 2023-06-13 — — CN disclosed
WO-2023013755-A1 CANCER PEPTIDE VACCINE COCKTAIL FORMULATION AMD METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2023-02-09 — — WO disclosed
WO-2022025093-A1 CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2022-02-03 — — WO disclosed
WO-2022025093-A1 CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2022-02-03 — — WO disclosed
Send feedback